NEW YORK (GenomeWeb News) – Integrated DNA Technologies today announced that it has created a new business unit called Clinical and Commercial Manufacturing, which will manufacture oligonucleotides for use in diagnostic products.
The firm also said that it has received ISO 13485:2003 certification at its facility in Coralville, Iowa, which houses the new unit.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.